Antiestrogens in the treatment of breast cancer
- 1 December 1976
- journal article
- research article
- Published by Elsevier in Cancer Treatment Reviews
- Vol. 3 (4) , 205-216
- https://doi.org/10.1016/s0305-7372(76)80010-2
Abstract
No abstract availableKeywords
This publication has 44 references indexed in Scilit:
- Controlled clinical trial of L-dopa and nafoxidine in advanced breast cancer: an E.O.R.T.C. study.BMJ, 1975
- Oestrogen receptors and antagonism of steroid hormone actionNature, 1974
- Antioestrogens in Treatment of Breast Cancer: Value of Nafoxidine in 52 Advanced CasesBMJ, 1974
- Estrogen receptor · anti-estrogen complex: Atypical binding by uterine nuclei and effects on uterine growthSteroids, 1973
- Oestrogen Receptor in Human Breast Cancer Tissue and Response to Endocrine TherapyBMJ, 1973
- Anti-estrogens and Plasma Proteins. I. Clomiphene and Isomers, Ethamoxytriphetol, U-ll,100A and U-11,555AJournal of Clinical Endocrinology & Metabolism, 1973
- A New Anti-oestrogenic Agent in Late Breast Cancer: An Early Clinical Appraisal of ICI46474British Journal of Cancer, 1971
- Sex hormones and renal neoplasia.Inhibition of tumor of hamster kidney by an estrogen antagonist, an agent of possible therapeutic value in manCancer, 1967
- NONSTEROIDAL ESTROGEN ANTAGONISTSClinical Obstetrics and Gynecology, 1967
- Persistence of Urinary Oestrogen Excretion After Oophorectomy and AdrenalectomyBMJ, 1957